All five trials met the primary objective of excluding an increased risk of cardiovascular disease in patients treated with DPP-4 inhibitors, however, none were associated with any cardiovascular benefit ( GLP-1 Receptor Agonists The cardiovascular safety of GLP-1RA have been assessed in seven clinical trials enrolling 60,090 patients (7780)
Kuhn KS, Schuhmann K, Stehle P, Darmaun D, Frst P
Changing Your Injection Day: If you want to permanently move your injection from, say, Wednesday to Sunday, you can do so as long as there are at least 3 days between your last dose and your new dose day
Originally developed to treat Type 2 diabetes, GLP-1 receptor agonists have expanded into weight management and other metabolic conditions
As a result, some people are filing Wegovy lawsuits